Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
作者信息
Nagai Y, Hayakawa T, Abe T, Nomura G
出版信息
Diabetes Care. 2000 Nov;23(11):1703. doi: 10.2337/diacare.23.11.1703b.
PMID:11092296
Abstract
摘要
相似文献
1
Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
Diabetes Care. 2000 Nov;23(11):1703. doi: 10.2337/diacare.23.11.1703b.
2
Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients.
Adv Ther. 2009 Jun;26(6):660-6. doi: 10.1007/s12325-009-0040-7. Epub 2009 Jun 30.
3
Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients.
Diabetes Res Clin Pract. 2002 Feb;55(2):99-103. doi: 10.1016/s0168-8227(01)00286-8.
4
Effect of gentamicin on serum digoxin level in patients with congestive heart failure.
Pharm World Sci. 2004 Apr;26(2):107-9. doi: 10.1023/b:phar.0000018594.26809.87.
5
A possible interaction of potential clinical interest between digoxin and acarbose.
Clin Pharmacol Ther. 1996 Nov;60(5):589-92. doi: 10.1016/S0009-9236(96)90156-3.
6
[Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
Nihon Rinsho. 2002 Sep;60 Suppl 9:464-9.
7
Comparison of acarbose and voglibose in diabetes patients who are inadequately controlled with basal insulin treatment: randomized, parallel, open-label, active-controlled study.
J Korean Med Sci. 2014 Jan;29(1):90-7. doi: 10.3346/jkms.2014.29.1.90. Epub 2013 Dec 26.
8
Omeprazole does not modulate pharmacokinetic of digoxin in patients with heart failure.
Int J Cardiol. 2015 Jan 20;179:343-4. doi: 10.1016/j.ijcard.2014.11.062. Epub 2014 Nov 7.
9
[alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
Nihon Rinsho. 2002 Sep;60 Suppl 9:393-8.
10
Do therapeutic doses of acarbose alter the pharmacokinetics of digoxin?
Isr Med Assoc J. 2002 Oct;4(10):772-5.
引用本文的文献
1
Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.
Drug Saf. 2005 Jul;28(7):601-631. doi: 10.2165/00002018-200528070-00004.
Zotero 插件